Sepsis Diagnostics Market Trends Estimates High Demand by 2027

By -

Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis dia

(EMAILWIRE.COM, November 06, 2019 ) Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.

Market Size
The Sepsis Diagnostics Market is projected to reach USD 869.7 million by 2027 from USD 396.6 million in 2018, at a CAGR of 9.1% during the forecast period.

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155

Based on technology, the biomarkers segment is expected to register the highest growth rate during the forecast period
The global sepsis diagnostics market is segmented into— microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to various advantages offered by this technique in the diagnosis of sepsis and growing need for early disease diagnosis.

Based on product, the blood culture media segment accounted for the largest share of the market in 2018
The global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. In 2018, the blood culture media segment accounted for the largest share of the market owing to the increased used of blood culture media as it is the standard method for diagnosis of sepsis across the globe.

Recent Developments
• In July 2016, bioMérieux received FDA approval for the expanded use of its VIDAS BRAHMS PCT (Procalcitonin) assay. Through this, it introduced innovative products in the market, which enabled it to garner a higher market share.
• In August 2017, BD received FDA approval for its BD BACTEC Standard Aerobic and Standard Anaerobic blood culture bottles in plastic.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more